Lifestyle Behaviors and Health-Related Quality of Life in Long-Term Survivors of Acute Myeloid Leukemia: An International Survivorship Study By the Gimema, EORTC Quality of Life and Leukemia Groups
Fabio Efficace(Fondazione Gimema Onlus), Frédéric Baron(University of Liège), Laura Cannella(Fondazione Gimema Onlus), Nicola Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Luca Maurillo(University of Rome Tor Vergata), Meltem Kurt Yüksel(Ankara University), Lorella Melillo(San Antonio College), Nunzio Filardi, Daniele Vallisa(Ospedaliera di Piacenza), Annalisa Imovilli(Azienda Sanitaria Unità Locale di Reggio Emilia), Martina Quattrone(Università Cattolica del Sacro Cuore), Alberto Brini(Fondazione Gimema Onlus), Xavier Thomas(Hôpital Lyon Sud), Marco Vignetti(Fondazione Gimema Onlus), Matevž Škerget(University of Ljubljana), Maria Ciccone(Arcispedale Sant'Anna), Capria Saveria(Sapienza University of Rome), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Silvia Maria Trisolini(Radboud University Nijmegen), Monica Crugnola(Ospedale di Parma), Irina Panovska Stavridis, Roberto M. Lemoli(University of Genoa)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k